메뉴 건너뛰기




Volumn 22, Issue 6, 2007, Pages 815-820

Effect of esomeprazole and rabeprazole on intragastric pH in healthy Chinese: An open, randomized crossover trial

Author keywords

Acid related diseases; CYP2C19; Esomeprazole; Intragastric pH; Rabeprazole

Indexed keywords

CYTOCHROME P450 2C19; ESOMEPRAZOLE; RABEPRAZOLE;

EID: 34250329615     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2006.04709.x     Document Type: Article
Times cited : (17)

References (27)
  • 1
    • 0026803020 scopus 로고
    • Appropriate acid suppression for the management of gastro-oesophageal reflux disease
    • Bell NJ, Burget D, Howden CW et al. Appropriate acid suppression for the management of gastro-oesophageal reflux disease. Digestion 1992 51 (Suppl. 1 59 67.
    • (1992) Digestion , vol.511 , pp. 59-67
    • Bell, N.J.1    Burget, D.2    Howden, C.W.3
  • 2
    • 0028309047 scopus 로고
    • Appropriate acid suppression for optimal healing of duodenal ulcer and gastro-oesophageal reflux disease
    • Howden CW, Burget DW, Hunt RH. Appropriate acid suppression for optimal healing of duodenal ulcer and gastro-oesophageal reflux disease. Scand. J. Gastroenterol. Suppl. 1994 201 : 79 82.
    • (1994) Scand. J. Gastroenterol. Suppl. , vol.201 , pp. 79-82
    • Howden, C.W.1    Burget, D.W.2    Hunt, R.H.3
  • 3
    • 0029811274 scopus 로고    scopus 로고
    • Role of acid and duodenogastroesophageal reflux in gastroesophageal reflux disease
    • Vaezi MF, Richter JE. Role of acid and duodenogastroesophageal reflux in gastroesophageal reflux disease. Gastroenterology 1996 111 : 1192 9.
    • (1996) Gastroenterology , vol.111 , pp. 1192-1199
    • Vaezi, M.F.1    Richter, J.E.2
  • 4
    • 85034892766 scopus 로고
    • Sensitivity of esophageal mucosa to pH in gastroesophageal reflux disease
    • Smith JL, Opekun AR, Larkai E et al. Sensitivity of esophageal mucosa to pH in gastroesophageal reflux disease. Gastroenterology 1989 96 : 683 9.
    • (1989) Gastroenterology , vol.96 , pp. 683-689
    • Smith, J.L.1    Opekun, A.R.2    Larkai, E.3
  • 5
    • 0033548841 scopus 로고    scopus 로고
    • Importance of pH control in the management of GERD
    • Hunt RH. Importance of pH control in the management of GERD. Arch. Intern. Med. 1999 159 : 649 57.
    • (1999) Arch. Intern. Med. , vol.159 , pp. 649-657
    • Hunt, R.H.1
  • 6
    • 0034798223 scopus 로고    scopus 로고
    • Pharmacokinetics and pharmacodynamics of esomeprazole, the S-isomer of omeprazole
    • Andersson T, Rohss K, Bredberg E et al. Pharmacokinetics and pharmacodynamics of esomeprazole, the S-isomer of omeprazole. Aliment. Pharmacol. Ther. 2001 15 : 1563 9.
    • (2001) Aliment. Pharmacol. Ther. , vol.15 , pp. 1563-1569
    • Andersson, T.1    Rohss, K.2    Bredberg, E.3
  • 7
    • 0034466498 scopus 로고    scopus 로고
    • Pharmacokinetics of esomeprazole after oral and intravenous administration of single and repeated doses to healthy subjects
    • Hassan-Alin M, Andersson E, Bredberg E et al. Pharmacokinetics of esomeprazole after oral and intravenous administration of single and repeated doses to healthy subjects. Eur. J. Clin. Pharmacol. 2000 56 : 665 70.
    • (2000) Eur. J. Clin. Pharmacol. , vol.56 , pp. 665-670
    • Hassan-Alin, M.1    Andersson, E.2    Bredberg, E.3
  • 8
    • 0033947414 scopus 로고    scopus 로고
    • Esomeprazole provides improved acid control vs omeprazole in patients with symptoms of gastro-oesophageal reflux disease
    • Lind T, Rydberg L, Kyleback A et al. Esomeprazole provides improved acid control vs omeprazole in patients with symptoms of gastro-oesophageal reflux disease. Aliment. Pharmacol. Ther. 2000 14 : 861 7.
    • (2000) Aliment. Pharmacol. Ther. , vol.14 , pp. 861-867
    • Lind, T.1    Rydberg, L.2    Kyleback, A.3
  • 9
    • 0036238720 scopus 로고    scopus 로고
    • Effect of esomeprazole 40 mg vs omeprazole 40 mg on 24-hour intragastric pH in patients with symptoms of gastroesophageal reflux disease
    • Rohss K, Hasselgren G, Hedenstrom H. Effect of esomeprazole 40 mg vs omeprazole 40 mg on 24-hour intragastric pH in patients with symptoms of gastroesophageal reflux disease. Dig. Dis. Sci. 2002 47 : 954 8.
    • (2002) Dig. Dis. Sci. , vol.47 , pp. 954-958
    • Rohss, K.1    Hasselgren, G.2    Hedenstrom, H.3
  • 10
    • 1342280463 scopus 로고    scopus 로고
    • Esomeprazole 40 mg provides improved intragastric acid control as compared with lansoprazole 30 mg and rabeprazole 20 mg in healthy volunteers
    • Wilder-Smith CH, Rohss K, Nilsson-Pieschl C et al. Esomeprazole 40 mg provides improved intragastric acid control as compared with lansoprazole 30 mg and rabeprazole 20 mg in healthy volunteers. Digestion 2003 68 : 184 8.
    • (2003) Digestion , vol.68 , pp. 184-188
    • Wilder-Smith, C.H.1    Rohss, K.2    Nilsson-Pieschl, C.3
  • 11
    • 10644282356 scopus 로고    scopus 로고
    • Esomeprazole 40 mg i.v. provides faster and more effective intragastric acid control than pantoprazole 40 mg i.v.: Results of a randomized study
    • Wilder-Smith CH, Rohss K, Bondarov P et al. Esomeprazole 40 mg i.v. provides faster and more effective intragastric acid control than pantoprazole 40 mg i.v.: results of a randomized study. Aliment. Pharmacol. Ther. 2004 20 : 1099 104.
    • (2004) Aliment. Pharmacol. Ther. , vol.20 , pp. 1099-1104
    • Wilder-Smith, C.H.1    Rohss, K.2    Bondarov, P.3
  • 12
    • 8744284238 scopus 로고    scopus 로고
    • Esomeprazole 40 mg provides more effective intragastric acid control than lansoprazole 30 mg, omeprazole 20 mg, pantoprazole 40 mg and rabeprazole 20 mg in patients with gastro-oesophageal reflux symptoms
    • Rohss K, Lind T, Wilder-Smith C. Esomeprazole 40 mg provides more effective intragastric acid control than lansoprazole 30 mg, omeprazole 20 mg, pantoprazole 40 mg and rabeprazole 20 mg in patients with gastro-oesophageal reflux symptoms. Eur. J. Clin. Pharmacol. 2004 60 : 531 9.
    • (2004) Eur. J. Clin. Pharmacol. , vol.60 , pp. 531-539
    • Rohss, K.1    Lind, T.2    Wilder-Smith, C.3
  • 13
    • 18144440017 scopus 로고    scopus 로고
    • Genetic variations of S-mephenytoin 4′-hydroxylase (CYP2C19) in the Chinese population
    • Xie HG. Genetic variations of S-mephenytoin 4′-hydroxylase (CYP2C19) in the Chinese population. Life Sci. 2000 66 : PL175 81.
    • (2000) Life Sci. , vol.66
    • Xie, H.G.1
  • 14
    • 0030580125 scopus 로고    scopus 로고
    • Genotype analysis of the CYP 2C19 gene in the Japanese population
    • Tsuneoka T, Fukushima K, Yoshinori M et al. Genotype analysis of the CYP 2C19 gene in the Japanese population. Life Sci. 1996 20 : 1711 15.
    • (1996) Life Sci. , vol.20 , pp. 1711-1715
    • Tsuneoka, T.1    Fukushima, K.2    Yoshinori, M.3
  • 15
    • 0036127851 scopus 로고    scopus 로고
    • Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis
    • Castell DO, Kahrilas PJ, Richter JE et al. Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis. Am. J. Gastroenterol. 2002 97 : 575 83.
    • (2002) Am. J. Gastroenterol. , vol.97 , pp. 575-583
    • Castell, D.O.1    Kahrilas, P.J.2    Richter, J.E.3
  • 16
    • 0033785204 scopus 로고    scopus 로고
    • Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux esophagitis patients: A randomized controlled trial
    • Kahrilas PJ, Falk GW, Johnson DA et al. Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux esophagitis patients: a randomized controlled trial. Aliment. Pharmacol. Ther. 2000 14 : 1249 58.
    • (2000) Aliment. Pharmacol. Ther. , vol.14 , pp. 1249-1258
    • Kahrilas, P.J.1    Falk, G.W.2    Johnson, D.A.3
  • 17
    • 0034783326 scopus 로고    scopus 로고
    • Systematic review of proton pump inhibitors for the acute treatment of reflux esophagitis
    • Edwards SJ, Lind T, Lundell L. Systematic review of proton pump inhibitors for the acute treatment of reflux esophagitis. Aliment. Pharmacol. Ther. 2001 15 : 1729 36.
    • (2001) Aliment. Pharmacol. Ther. , vol.15 , pp. 1729-1736
    • Edwards, S.J.1    Lind, T.2    Lundell, L.3
  • 18
    • 0035114856 scopus 로고    scopus 로고
    • Esomeprazole 20 mg maintains symptom control in endoscopy-negative gastro-esophageal reflux disease: A controlled trial of 'on-demand' therapy for 6 months
    • Talley NJ, Lauritsen K, Tunturi-Hihnala H et al. Esomeprazole 20 mg maintains symptom control in endoscopy-negative gastro-esophageal reflux disease: a controlled trial of 'on-demand' therapy for 6 months. Aliment. Pharmacol. Ther. 2001 15 : 347 54.
    • (2001) Aliment. Pharmacol. Ther. , vol.15 , pp. 347-354
    • Talley, N.J.1    Lauritsen, K.2    Tunturi-Hihnala, H.3
  • 19
    • 0034046560 scopus 로고    scopus 로고
    • A placebo-controlled study to assess the effects of 7-day dosing with 10, 20 and 40 mg rabeprazole on 24-h intragastric acidity and plasma gastrin in healthy male subjects
    • Williams MP, Blanshard C, Millson C et al. A placebo-controlled study to assess the effects of 7-day dosing with 10, 20 and 40 mg rabeprazole on 24-h intragastric acidity and plasma gastrin in healthy male subjects. Aliment. Pharmacol. Ther. 2000 14 : 691 9.
    • (2000) Aliment. Pharmacol. Ther. , vol.14 , pp. 691-699
    • Williams, M.P.1    Blanshard, C.2    Millson, C.3
  • 20
    • 0008422869 scopus 로고    scopus 로고
    • Rabeprazole versus omeprazole in preventing relapse of erosive or ulcerative gastroesophageal reflux disease: A double-bind, multicenter, European trial
    • Thjodleifsson B, Becker JA, Dekkers C et al. Rabeprazole versus omeprazole in preventing relapse of erosive or ulcerative gastroesophageal reflux disease: a double-bind, multicenter, European trial. Dig. Dis. Sci. 2000 45 : 845 53.
    • (2000) Dig. Dis. Sci. , vol.45 , pp. 845-853
    • Thjodleifsson, B.1    Becker, J.A.2    Dekkers, C.3
  • 21
    • 0021684926 scopus 로고
    • Mephenytoin hydroxylation deficiency in Caucasian. Frequency of a new oxidative drug metabolism polymorphism
    • Wedlund PJ, Aslanian WS, McAllister CB, Wilkinson GR, Branch RA. Mephenytoin hydroxylation deficiency in Caucasian. Frequency of a new oxidative drug metabolism polymorphism. Clin. Pharmacol. Ther. 1984 36 : 773 80.
    • (1984) Clin. Pharmacol. Ther. , vol.36 , pp. 773-780
    • Wedlund, P.J.1    Aslanian, W.S.2    McAllister, C.B.3    Wilkinson, G.R.4    Branch, R.A.5
  • 22
    • 0030444707 scopus 로고    scopus 로고
    • Genotyping of S-mephenytoin 4′-hydroxylation in an extended Japanese population
    • Kubota T, Chiba K, Ishizaki T. Genotyping of S-mephenytoin 4′-hydroxylation in an extended Japanese population. Clin. Pharmacol. Ther. 1996 60 : 661 6.
    • (1996) Clin. Pharmacol. Ther. , vol.60 , pp. 661-666
    • Kubota, T.1    Chiba, K.2    Ishizaki, T.3
  • 23
    • 0026705708 scopus 로고
    • Incidence of S-mephenytoin hydroxylation deficiency in a Korean population and the interphenotypic differences in diazepam pharmacokinetics
    • Sohn DR, Kusaka M, Ishizaki T et al. Incidence of S-mephenytoin hydroxylation deficiency in a Korean population and the interphenotypic differences in diazepam pharmacokinetics. Clin. Pharmacol. Ther. 1992 52 : 160 9.
    • (1992) Clin. Pharmacol. Ther. , vol.52 , pp. 160-169
    • Sohn, D.R.1    Kusaka, M.2    Ishizaki, T.3
  • 24
    • 0024442372 scopus 로고
    • Metoprolol and mephenytoin oxidation polymorphisms in Far Eastern Oriental subjects: Japanese versus mainland Chinese
    • Horai Y, Nakano M, Ishizaka T et al. Metoprolol and mephenytoin oxidation polymorphisms in Far Eastern Oriental subjects: Japanese versus mainland Chinese. Clin. Pharmacol. Ther. 1989 46 : 198 207.
    • (1989) Clin. Pharmacol. Ther. , vol.46 , pp. 198-207
    • Horai, Y.1    Nakano, M.2    Ishizaka, T.3
  • 25
    • 0026393989 scopus 로고
    • The prevalence of Helicobacter pylori infection in the People's Republic of China
    • Li YY, Du Hu PJ, GG et al. The prevalence of Helicobacter pylori infection in the People's Republic of China. Am. J. Gastroenterol. 1991 86 : 446 9.
    • (1991) Am. J. Gastroenterol. , vol.86 , pp. 446-449
    • Li, Y.Y.1    Du Hu, P.J.G.G.2
  • 26
    • 0036306162 scopus 로고    scopus 로고
    • Comparison of seroepidemiology of Helicobacter Pylori in Shanghai urban area during 1990 and 2001
    • Chen S, Xiao S, Liu W, Xu W et al. Comparison of seroepidemiology of Helicobacter Pylori in Shanghai urban area during 1990 and 2001. Chin J. Gastroenterol. 2002 7 : 146 8.
    • (2002) Chin J. Gastroenterol. , vol.7 , pp. 146-148
    • Chen, S.1    Xiao, S.2    Liu, W.3    Xu, W.4
  • 27
    • 0032586730 scopus 로고    scopus 로고
    • CYP 2C19 genotype status and effect of omeprazole on intragastric pH in humans
    • Furuta T, Ohashi K, Kosuge K et al. CYP 2C19 genotype status and effect of omeprazole on intragastric pH in humans. Clin. Pharmacol. Ther. 1999 65 : 552 61.
    • (1999) Clin. Pharmacol. Ther. , vol.65 , pp. 552-561
    • Furuta, T.1    Ohashi, K.2    Kosuge, K.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.